ArticleFrontiers in oncology2021

Immune-Related Adverse Events and Their Association With the Effectiveness of PD-1/PD-L1 Inhibitors in Non-Small Cell Lung Cancer: A Real-World Study From China.

Xiaoling Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.